AAAAAA
Results: 1-25/61
Authors:
Basile, VS
Ozdemir, V
Masellis, M
Meltzer, HY
Lieberman, JA
Potkin, SG
Macciardi, FM
Petronis, A
Kennedy, JL
Citation: Vs. Basile et al., Lack of association between serotonin-2A receptor gene (HTR2A) polymorphisms and tardive dyskinesia in schizophrenia, MOL PSYCHI, 6(2), 2001, pp. 230-234
Authors:
Citrome, L
Volavka, J
Czobor, P
Sheitman, B
Lindenmayer, JP
McEvoy, J
Cooper, TB
Chakos, M
Lieberman, JA
Citation: L. Citrome et al., Effects of clozapine, olanzapine, risperidone, and haloperidol on hostility among patients with schizophrenia, PSYCH SERV, 52(11), 2001, pp. 1510-1514
Authors:
Schneider, LS
Tariot, PN
Lyketsos, CG
Dagerman, KS
Davis, KL
Davis, S
Hsiao, JK
Jeste, DV
Katz, IR
Olin, JT
Pollock, BG
Rabins, PV
Rosenheck, RA
Small, GW
Lebowitz, B
Lieberman, JA
Citation: Ls. Schneider et al., National Institute of Mental Health Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) - Alzheimer disease trial methodology, AM J GER PS, 9(4), 2001, pp. 346-360
Authors:
Lieberman, JA
Citation: Ja. Lieberman, Starting a career in psychiatric research - The lessons of experience, ACAD PSYCHI, 25(1), 2001, pp. 28-30
Authors:
Urakubo, A
Jarskog, LF
Lieberman, JA
Gilmore, JH
Citation: A. Urakubo et al., Prenatal exposure to maternal infection alters cytokine expression in the placenta, amniotic fluid, and fetal brain, SCHIZOPHR R, 47(1), 2001, pp. 27-36
Authors:
Masellis, M
Basile, VS
Meltzer, HY
Lieberman, JA
Sevy, S
Goldman, DA
Hamblin, MW
Macciardi, FM
Kennedy, JL
Citation: M. Masellis et al., Lack of association between the T -> C 267 serotonin 5-MT6 receptor gene (HTR6) polymorphism and prediction of response to clozapine in schizophrenia, SCHIZOPHR R, 47(1), 2001, pp. 49-58
Authors:
Aghajanian, GK
Lieberman, JA
Citation: Gk. Aghajanian et Ja. Lieberman, Caveat emptor: Editors beware - Response, NEUROPSYCH, 24(3), 2001, pp. 335-336
Authors:
Maynard, TM
Sikich, L
Lieberman, JA
LaMantia, AS
Citation: Tm. Maynard et al., Neural development, cell-cell signaling, and the "two-hit" hypothesis of schizophrenia, SCHIZO BULL, 27(3), 2001, pp. 457-476
Authors:
Lieberman, JA
Citation: Ja. Lieberman, Hypothesis and hypothesis testing in the clinical trial, J CLIN PSY, 62, 2001, pp. 5-10
Authors:
Basile, VS
Masellis, M
McIntyre, RS
Meltzer, HY
Lieberman, JA
Kennedy, JL
Citation: Vs. Basile et al., Genetic dissection of atypical antipsychotic-induced weight gain: Novel preliminary data on the pharmacogenetic puzzle, J CLIN PSY, 62, 2001, pp. 45-66
Authors:
Strous, RD
Pollack, S
Robinson, D
Sheitman, B
Lieberman, JA
Citation: Rd. Strous et al., Seasonal admission patterns in first episode psychosis, chronic schizophrenia, and nonschizophrenic psychoses, J NERV MENT, 189(9), 2001, pp. 642-644
Authors:
Miyamoto, S
Mailman, RB
Lieberman, JA
Duncan, GE
Citation: S. Miyamoto et al., Blunted brain metabolic response to ketamine in mice lacking D-1A dopaminereceptors, BRAIN RES, 894(2), 2001, pp. 167-180
Authors:
Marx, CE
Jarskog, LF
Lauder, JM
Lieberman, JA
Gilmore, JH
Citation: Ce. Marx et al., Cytokine effects on cortical neuron MAP-2 immunoreactivity: Implications for schizophrenia, BIOL PSYCHI, 50(10), 2001, pp. 743-749
Authors:
Basile, VS
Ozdemir, V
Masellis, M
Walker, ML
Heltzer, HY
Lieberman, JA
Potkin, SG
Alva, G
Kalow, W
Macciardi, FM
Kennedy, JL
Citation: Vs. Basile et al., A functional polymorphism of the cytochrome P450 1A2 (CYP1A2) gene: association with tardive dyskinesia in schizophrenia, MOL PSYCHI, 5(4), 2000, pp. 410-417
Authors:
Lieberman, JA
Golden, R
Stroup, S
McEvoy, J
Citation: Ja. Lieberman et al., Drugs of the psychopharmacological revolution in clinical psychiatry, PSYCH SERV, 51(10), 2000, pp. 1254-1258
Authors:
Sheitman, BB
Murray, MG
Snyder, JA
Silva, S
Goldman, R
Chakos, M
Volavka, J
Lieberman, JA
Citation: Bb. Sheitman et al., IQ scores of treatment-resistant schizophrenia patients before and after the onset of the illness, SCHIZOPHR R, 46(2-3), 2000, pp. 203-207
Authors:
Perkins, DO
Leserman, J
Jarskog, LF
Graham, K
Kazmer, J
Lieberman, JA
Citation: Do. Perkins et al., Characterizing and dating the onset of symptoms in psychotic illness: the Symptom Onset in Schizophrenia (SOS) inventory, SCHIZOPHR R, 44(1), 2000, pp. 1-10
Authors:
Szeszko, PR
Bilder, RM
Lencz, T
Ashtari, M
Goldman, RS
Reiter, G
Wu, HW
Lieberman, JA
Citation: Pr. Szeszko et al., Reduced anterior cingulate gyrus volume correlates with executive dysfunction in men with first-episode schizophrenia, SCHIZOPHR R, 43(2-3), 2000, pp. 97-108
Authors:
Levy, DL
Lajonchere, CM
Dorogusker, B
Min, D
Lee, S
Tartaglini, A
Lieberman, JA
Mendell, NR
Citation: Dl. Levy et al., Quantitative characterization of eye tracking dysfunction in schizophrenia, SCHIZOPHR R, 42(3), 2000, pp. 171-185
Authors:
Lewis, DA
Lieberman, JA
Citation: Da. Lewis et Ja. Lieberman, Catching up on schizophrenia: Natural history and neurobiology, NEURON, 28(2), 2000, pp. 325-334
Authors:
Miyamoto, S
Leipzig, JN
Lieberman, JA
Duncan, GE
Citation: S. Miyamoto et al., Effects of ketamine, MK-801, and amphetamine on regional brain 2-deoxyglucose uptake in freely moving mice, NEUROPSYCH, 22(4), 2000, pp. 400-412
Authors:
Lieberman, JA
Citation: Ja. Lieberman, Clinical research in the age of neuroscience, NEUROPSYCH, 22(1), 2000, pp. 1-3
Authors:
Overstreet, DH
Moy, SS
Lubin, DA
Gause, LR
Lieberman, JA
Johns, JM
Citation: Dh. Overstreet et al., Enduring effects of prenatal cocaine administration on emotional behavior in rats, PHYSL BEHAV, 70(1-2), 2000, pp. 149-156
Authors:
Duncan, GE
Miyamoto, S
Leipzig, JN
Lieberman, JA
Citation: Ge. Duncan et al., Comparison of the effects of clozapine, risperidone, and olanzapine on ketamine-induced alterations in regional brain metabolism, J PHARM EXP, 293(1), 2000, pp. 8-14
Authors:
Marx, CE
Jarskog, LF
Lauder, JM
Gilmore, JH
Lieberman, JA
Morrow, AL
Citation: Ce. Marx et al., Neurosteroid modulation of embryonic neuronal survival in vitro following anoxia, BRAIN RES, 871(1), 2000, pp. 104-112